EUthyroid held a policy meeting in Brussels on April 28, in order to promote harmonisation of iodine deficiency (ID) prevention programmes in Europe. Presentations from Henry Völzke (University Medicine Greifswald, DE), John Lazarus (Iodine Global Network, CA) and Rodrigo Moreno-Reyes (Erasme-ULB, BE) summarised the aims of EUthyroid, the current iodine status in Europe and a review of ID from the past to the present. Yvette Azzopardi (DG SANTE, BE) reviewed the legal issues around the ability of the EU to advise and legislate concerning health related topics.
From left to right: Stefan Grünert, biolution GmbH, AT; Ans Eilander, Unilever plc, NL; Iris Grünert, biolution GmbH, AT; Laurence Doughan, Belgian Ministry of Health, BE; Rodrigo Moreno-Reyes, Erasme-ULB, BE; Yvette Azzopardi, DG SANTE, BE; Henry Völzke, University Medicine Greifswald, DE; Wouter Lox, EuSalt, BE; John Lazarus, Iodine Global Network, CA; Lilou van Lieshout, International Life Sciences Institute Europe, BE; Katja Hora SQM Europe N.V., BE; Diana Albrecht, University Medicine Greifswald DE
presentations providing a durable basis towards a dissemination strategy targeting major stakeholders for the remaining time of EUthyroid, which ends in 2018 with a conference on IDD-prevention.
University Medicine Greifswald, Germany & EUthyroid
Department for Health and Food Safety (DG SANTE), EC
Belgian Ministry of Health
Unilever plc & Industrial partner of the Nutrient Intake Optimisation Taskforce of ILSI Europe
CEO biolution & EUthyroid
biolution & EUthyroid
SQM Europe N.V. & Industrial partner of the Nutrient Intake Optimisation Taskforce of ILSI Europe
IGN & EUthyroid
Lilou van Lieshout
Erasme-ULB & EUthyroid
University Medicine Greifswald & EUthyroid